Potential of miR-4477a to treat breast cancer using a CD8+ co-culture model

What is it about?

The aim of this study was to examine how a type of molecule called 'microRNA-4477a' affects the 'PD-1/PD-L1' interaction in two types of breast cells (MCF-7 and HME1). The study also wanted to find out if microRNA-4477a could be used in cancer treatment by looking at how it affects CD8+ T cells.

Featured Image

Photo by CDC on Unsplash

Photo by CDC on Unsplash

Why is it important?

Studies in the lab showed that a very small amount of a substance called miR-4477a could cause problems for a type of breast cancer cell called MCF-7. It stopped a gene called PD-L1 from working, reduced the levels of a protein called sPD-L1, and stopped the cells from moving. The in vitro co-culture analysis showed that cancer cells could not avoid being found and attacked by T cells (CD8+) because miR-4477a stopped PD-L1 from being expressed.

Perspectives

“

This study suggests that a molecule called miR-4477a could be used in cancer treatment to boost the immune system. It has also been shown to have strong anticancer effects in breast cancer, making it a potential addition to cancer therapy.

”